Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Thyrotropin alfa
Drug ID BADD_D02208
Description Thyrotropin alfa is a recombinant form of thyroid stimulating hormone used in performing certain tests in patients who have or have had thyroid cancer. It is also used along with a radioactive agent to destroy remaining thyroid tissue in certain patients who have had their thyroid gland removed because of thyroid cancer. It is a heterodimeric glycoprotein comprised of two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites and a beta subunit of 112 residues containing one N-linked glycosylation site. The alpha subunit of thyrotropin alfa, which is the effector region responsible for the stimulation of adenylate cyclase, displays close structural similarity with the alpha subunit of human chorionic gonadotropin (hCG), luteinizing hormone (LH), and follicle-stimulating hormone (FSH). The beta subunit (TSHB) bestows its receptor specificity due to the uniqueness to TSH. The amino acid sequence of thyrotropin alfa is identical to that of human pituitary thyroid stimulating hormone.
Indications and Usage For detection of residueal or recurrent thyroid cancer
Marketing Status approved; vet_approved
ATC Code H01AB01
DrugBank ID DB00024
KEGG ID D06120
MeSH ID D057073
PubChem ID 32281
TTD Drug ID Not Available
NDC Product Code 58468-0030
UNII AVX3D5A4LM
Synonyms Thyrotropin Alfa | Alfa, Thyrotropin | Recombinant Human TSH | Human TSH, Recombinant | TSH, Recombinant Human | rhTSH | Thyrogen
Chemical Information
Molecular Formula C16H22N6O4
CAS Registry Number 194100-83-9
SMILES C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Arrhythmia supraventricular02.03.03.001---
Arthralgia15.01.02.001--
Asthenia08.01.01.001---
Blood cholesterol abnormal13.12.01.009---
Cerebrovascular accident17.08.01.007; 24.03.05.001--
Chills08.01.09.001; 15.05.03.016--
Death08.04.01.001--
Diarrhoea07.02.01.001--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Drug specific antibody present13.17.01.001---
Fatigue08.01.01.002--
Flushing08.01.03.025; 23.06.05.003; 24.03.01.002--
Headache17.14.01.001--
Hypercholesterolaemia14.08.01.001---
Insomnia17.15.03.002; 19.02.01.002--
Malaise08.01.01.003--
Myalgia15.05.02.001--
Nasopharyngitis11.01.13.002; 22.07.03.002---
Nausea07.01.07.001--
Paraesthesia17.02.06.005; 23.03.03.094--
Pruritus23.03.12.001--
Pyrexia08.05.02.003--
Rash23.03.13.001---
Urticaria10.01.06.001; 23.04.02.001--
Vomiting07.01.07.003--
Malignant neoplasm progression16.16.01.005---
Thyroglobulin present13.10.06.004---
The 1th Page    1    Total 1 Pages